TwistDx announces collaboration with Monsanto Company
To view your chosen Press Release please select from the list below
TwistDx Limited, a UK-based developer of point-of-use nucleic acid diagnostics, has entered into collaboration with Monsanto Company, a US-based agricultural company, to develop DNA-based field tests.
According to the agreement, the companies are using TwistDx's proprietary Recombinase Polymerase Amplification (RPA) technology to develop the tests. RPA is a novel DNA amplification technology. Monsanto plans to use the tests to enhance the efficiency with which biotechnology crops are delivered across the globe.
Under the terms of the agreement, TwistDx has received an undisclosed upfront payment. Additional payments could come in the form of research funding, payment upon reaching specific development milestones, and royalties from net sales resulting from commercialization of any test resulting from the collaboration.